文献速递脑血管病神经重症与神经感染

急性缺血性卒中血管内取栓术后造影剂脑病

Contrast-Induced Encephalopathy After Endovascular Thrombectomy for Acute Ischemic Stroke.
PubMed 文献 · Stroke · 2020-10-30

独立危险因素包括肾功能障碍(eGFR<45 mL/min per 1.73 m2,OR 5.77,95%CI 1.37-24.3,P=0.02)和卒中史(OR 4.96,95%CI 1.15-21.3,P=0.03);发生者功能预后良好可能性更低(OR 0.09,95%CI 0.01-0.87,P=0.04)。

要点

  • 取栓后临床恶化伴影像造影剂染色和水肿改变需警惕造影剂脑病。
  • 肾功能障碍(eGFR<45)和卒中史是造影剂脑病独立危险因素。
  • 发生造影剂脑病者功能预后良好可能性显著降低。

核心结论

  • 取栓后临床恶化伴影像造影剂染色和水肿改变时应怀疑造影剂脑病,尤其肾功能障碍或卒中史患者。

主要发现

  • 421例中7例(1.7%)发生造影剂脑病,表现为局灶神经体征恶化、昏迷和癫痫发作。
  • 造影剂脑病患者更易发生造影剂所致急性肾损伤,但两组造影剂用量相当。
  • 造影剂脑病独立危险因素为肾功能障碍(eGFR<45 mL/min per 1.73 m2,OR 5.77,95%CI 1.37-24.3,P=0.02)和卒中史(OR 4.96,95%CI 1.15-21.3,P=0.03)。
  • 造影剂脑病患者获得良好功能预后的可能性更低(OR 0.09,95%CI 0.01-0.87,P=0.04)。

关键数值与推荐

  • 造影剂脑病临床诊断标准为术后24小时内神经功能恶化或恢复延迟且无法用梗死或出血转化解释。
  • 影像学诊断标准为水肿改变超出梗死核心并伴造影剂染色。

临床怎么用

  • 取栓术后出现不明原因临床恶化时应行影像检查评估造影剂染色和水肿以识别造影剂脑病。
  • 对肾功能障碍或卒中史患者应提高造影剂脑病警惕并加强术后监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Contrast-induced encephalopathy (CIE) is a rare and underrecognized complication after endovascular thrombectomy (EVT) for acute ischemic stroke. This study investigated the incidence and risk factors of CIE in patients who underwent EVT. METHODS: Consecutive patients with acute ischemic stroke who received EVT between September 2014 and December 2019 at 2 medical centers were included. CIE was diagnosed on clinical criteria of neurological deterioration or delayed improvement within 24 hours after the procedure that was unexplained by the infarct or hemorrhagic transformation and radiological criterion of edematous change extending beyond the infarct core accompanied by contrast staining. RESULTS: Of 421 patients with acute ischemic stroke who received EVT, 7 (1.7%) developed CIE. The manifestations included worsening of focal neurological signs, coma, and seizure. Patients with CIE were more likely to experience contrast-induced acute kidney injury than were those without CIE, but the volume of contrast medium was comparable between the two groups. The independent risk factors for CIE included renal dysfunction (defined as an estimated glomerular filtration rate <45 mL/min per 1.73 m2; odds ratio, 5.77 [95% CI, 1.37-24.3]; P=0.02) and history of stroke (odds ratio, 4.96 [95% CI, 1.15-21.3]; P=0.03). Patients with CIE were less likely to achieve favorable functional outcomes (odds ratio, 0.09 [95% CI, 0.01-0.87]; P=0.04). CONCLUSIONS: CIE should be suspected in patients with clinical worsening after EVT accompanied by imaging evidence of contrast staining and edematous changes, especially in patients with renal dysfunction or history of stroke.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Chu YT, Lee KP, Chen CH, et al. Contrast-Induced Encephalopathy After Endovascular Thrombectomy for Acute Ischemic Stroke. Stroke. 2020. PMID: 33121385. doi:10.1161/STROKEAHA.120.031518

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。